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Background: In the avian sound localization circuit, nucleus magnocellularis (NM) projects bilaterally to nucleus
laminaris (NL), with ipsilateral and contralateral NM axon branches directed to dorsal and ventral NL dendrites,
respectively. We previously showed that the Eph receptor EphB2 is expressed in NL neuropil and NM axons during
development. Here we tested whether EphB2 contributes to NM-NL circuit formation.
Results: We found that misexpression of EphB2 in embryonic NM precursors significantly increased the number of
axon targeting errors from NM to contralateral NL in a cell-autonomous manner when forward signaling was
impaired. We also tested the effects of inhibiting forward signaling of different Eph receptor subclasses by injecting
soluble unclustered Fc-fusion proteins at stages when NM axons are approaching their NL target. Again we found
an increase in axon targeting errors compared to controls when forward signaling was impaired, an effect that was
significantly increased when both Eph receptor subclasses were inhibited together. In addition to axon targeting
errors, we also observed morphological abnormalities of the auditory nuclei when EphB2 forward signaling was
increased by E2 transfection, and when Eph-ephrin forward signaling was inhibited by E6-E8 injection of Eph
receptor fusion proteins.
Conclusions: These data suggest that EphB signaling has distinct functions in axon guidance and morphogenesis.
The results provide evidence that multiple Eph receptors work synergistically in the formation of precise
auditory circuitry.
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The sensory epithelium of the auditory system is unique
in that it contains an orderly representation of stimulus
frequency that lacks information about auditory space.
Our ability to localize sound sources relies on interaural
time differences (ITDs) and interaural level differences
(ILDs) encoded in auditory brainstem circuitry. Circuitry
that detects ITDs is well characterized in the avian audi-
tory brainstem (Figure 1), in which nucleus magnocellu-
laris (NM) receives tonotopically arranged auditory
afferents from the VIIIth nerve [1,2]. Each NM cell pro-
jects bilaterally to nucleus laminaris (NL), which con-
tains neurons that have bitufted dendrites [3] and act as* Correspondence: cramerk@uci.edu
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distribution, and reproduction in any mediumcoincidence detectors that respond maximally when sim-
ultaneous input is received on both dorsal and ventral
dendrites [4]. While axosomatic contacts are made on
both sides, ipsilateral NM axon branches contact dorsal
NL dendrites, whereas contralateral NM axon branches
contact ventral NL dendrites [5-7]. The contralateral
branches of NM axons terminate in delay lines in NL
[8-10], so that the location of NL neurons receiving
coincident bilateral input is correlated with the azi-
muth of the sound source [8,11,12].
During development, contralaterally projecting NM
axons cross the midline at E4 [13] and reach their target
between E6 and E8 [14], at the same time that auditory
brainstem nuclei begin to separate from the auditory an-
lage [14,15]. By E8, ipsilateral NM axon branches are
visible. Synaptic connections from NM to NL form by
E10, and axonal and synaptic refinement follow over theioMed Central Ltd. This is an Open Access article distributed under the terms of
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Figure 1 Schematized NM-NL circuit. (A) Illustration of a dissected
chick embryo brainstem at E10 with auditory nuclei (including NM
and NL) outlined bilaterally and the coronal plane of section for (B)
indicated with a dashed line. (B) Coronal section of an E10 chick
auditory brainstem with bisbenzimide nuclear staining. Bilateral
projections from a single representative right-sided NM cell are
schematized. Ipsilateral NM axon contacts dorsal NL neuropil with
divergent branches of similar length, while contralateral NM axon
contacts ventral NL neuropil with a delay line. Note the absence of
cells in the neuropil surrounding NL cells where NM axons synapse.
Scale bar = 0.5 mm in (A) and 100 μm in (B). VIII = eighth cranial
(vestibulocochlear) nerve.
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to NL are able to discriminate between the ventral ver-
sus dorsal dendrites of target cells with very few, if
any, errors [11,17,18]. We have previously reported that
Eph-ephrin signaling, known to be important for axon
guidance and cell migration in other systems [19-25] has
several distinct roles in the establishment of the NM-NL
circuit [26-28].
Eph receptors comprise the largest class of receptor
tyrosine kinases, and along with their ephrin ligands, are
categorized into A and B subclasses based on structural
similarity and binding affinities [29,30]. In general, EphA
receptors bind ephrin-A ligands, and EphB receptorsbind ephrin-B ligands, with two exceptions in which
EphA4 also binds ephrin-B ligands [29,31] and EphB2
also binds ephrin-A5 [32]. Both receptor and ligand are
membrane bound, with cell-cell interactions resulting in
bidirectional signaling [33,34] and either attractive or re-
pulsive cues to axons or migrating cells. The cell bearing
the Eph receptor undergoes “forward” signaling, while
the cell bearing the ephrin undergoes “reverse” signaling
[35]. Embryos with impaired Eph-ephrin signaling ex-
hibit a range of auditory defects including altered coch-
lear innervation and function [36,37], abnormal axon
targeting in the auditory brainstem [17,38-41] and sig-
nificantly impaired hearing [42,43].
At E10, when NM-NL contacts form, EphA4 is highly
expressed in the dorsal, but not ventral, neuropil of NL
[44]. In our previous study, we found that EphA4 misex-
pression resulted in a significant number of dorsoventral
targeting errors from NM to contralateral NL [17]. How-
ever, the majority of NM axons terminated in their ap-
propriate target region, suggesting that proper targeting
relies on the coordinated functions of several molecules
during development. We previously showed that several
other Eph family proteins are expressed in NM and NL
at the time that projections form [27]. Notably, EphB2 is
expressed in both the dorsal and ventral NL neuropil, as
well as in NM axons. In this study we tested whether
EphB2 acts to segregate NM axons to appropriate den-
dritic regions of NL. We misexpressed EphB2 in NM
cells using plasmid transfection or injected soluble Eph
fusion proteins to inhibit forward signaling through Eph
receptors in the region of NM axon growth, then exam-
ined the effects on the NM-NL pathway. We found that
altering Eph-ephrin forward signaling during develop-
ment of the NM-NL circuit resulted in impaired axon
targeting, and that both EphA and EphB classes play a
role in segregation of binaural inputs. Additionally, our
studies suggest that EphB signaling is needed for the
morphologic maturation of these auditory nuclei at sev-
eral stages of embryonic development.
Results
Transfection is limited to auditory nuclei and extensive
in NM cells
As we have previously shown [17,45], transfection of
auditory cell precursors by in ovo electroporation at E2
leads to prolonged plasmid expression as shown by
EGFP reporter expression and by immunolabeling of
protein encoded by the transfected plasmid. Transfec-
tion was directed focally to the auditory brainstem pre-
cursors at E2 by placing the electrodes at the level of r5
[46]. At E2, NM and NL cells are undergoing their final
mitotic divisions and rhombomere boundaries are vis-
ible. Following electroporation at E2, inspection of
embryos revealed normal rhombomere morphology at
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of whole brainstems dissected at E10 (Figure 2A). We
found extensive transfection throughout NM that
included cell bodies and axons, with more limited trans-
fection seen in NL. In cases with NL cell transfectionFigure 2 Transfection is limited to auditory nuclei as seen by
EGFP fluorescence. (A) Dissected chick brainstem at E10 following
in ovo electroporation at E2. Bilateral auditory nuclei are EGFP
positive, as are the axons connecting NM to contralateral NL (white
arrowheads). (B) Coronal section of E10 chick brainstem (left side) at
approximately the level shown by a black dashed line in (A) shows
transfection is extensive in but not limited to NM cells and their
axons. In the section shown here, three NL cells and their bipolar
tufts of dendrites within the cellular monolayer are visible by EGFP
fluorescence. (A, B) White arrowheads delineate the margins of
contralateral NM axons, and are oriented in (B) to indicate
anterograde direction from NM origin to contralateral target. Scale
bar = 1 mm in (A) and 100 μm in (B).(Figure 2B), the number of transfected NL cells were
outnumbered over 10:1 by NM transfected cells. A total
of 24 electroporated embryos met inclusion criteria
(described in Methods) and were used in the axon
targeting analysis, while 57 were used at least in part for
anatomical analyses.
Misexpression of EphB2 impairs axon targeting and NL
morphogenesis
Axon targeting in the NM-NL pathway was analyzed in
E10 embryos after transfection. Each embryo was con-
sidered a single data point, and targeting errors were
quantified across the central region of each right and left
NL. As expected, control embryos with EGFP transfec-
tion showed few contralateral NM axons in the dorsal
region of the NL neuropil (Figure 3A, A’), with
2.85 ± 0.80 errors per 400 μm of NL (n = 7; Figure 3D).
In embryos transfected with a full-length wild type
EphB2 (Figure 3B, B’) the mean number of targeting
errors was 7.17 ± 1.70 per 400 μm of NL (n = 6;
Figure 3D), which did not significantly differ from EGFP
controls (P= 0.09; Student’s t-test). To test the effect of
reduced EphB2 signaling, we examined embryos trans-
fected with kiEphB2, which acts as a dominant negative
to inhibit forward signaling by interfering with endogen-
ous receptor function [47] but acts similar to EphB2 in
its potential to activate reverse signaling. We found that
misexpression with kiEphB2 resulted in a significant in-
crease in axon targeting errors from NM to contralateral
NL (Figure 3C, C’). The mean number of targeting
errors was 14.73 ± 1.63 per 400 μm of NL (n = 11;
Figure 3D), which was significantly greater than that
seen in control embryos (P < 0.0001) or in EphB2-
transfected embryos (P= 0.0028). The significant in-
crease in errors associated with kiEphB2 compared to
EphB2 suggests that EphB2 forward signaling selectively
affects targeting of NM axons to appropriate dendritic
targets in NL and that it is a cell-autonomous effect
since NM (axons) rather than NL (target) cells were
transfected.
We examined the morphology of auditory brainstem
nuclei in electroporated embryos. During data collection,
abnormal NL morphologies were observed in which NL
was either not organized into a flattened cellular mono-
layer and/or was reduced in length. In some instances,
ipsilateral NM and NL were positioned in closer proxim-
ity to each other than expected for the age examined.
The percentages of embryos within each group meeting
any of these criteria for atypical NM-NL morphology are
shown in Figure 3E. Overall, 75% (12 of 16) of embryos
expressing functional EphB2 plasmids had an atypical
NL morphology compared to 6% (n = 17) and 4%
(n = 24) of embryos transfected with EGFP alone or
kiEphB2, respectively. Unlike EphB2 misexpression
Figure 3 Targeting errors are increased when EphB2 is misexpressed during development. (A-C, A’-C’) RDA trace of left-sided NL in E10
embryos following E2 transfection of EGFP control (A, A’), full-length EphB2 (B, B’), or kiEphB2 (C, C’) plasmid. (A, B, C) are original 20X images
with the outlined box expanded and color-inverted in (A’, B’, C’) to highlight fine processes of single axons crossing the NL cell body layer
inappropriately (white arrows). (D) Quantification of the mean number of axon targeting errors per group with SEM bars. (E) Percentage of
embryos in each group demonstrating atypical features of NL morphology, including a reduced length and/or a disorganized cellular layer. Scale
bar = 100 μm in (A-C) and 35 μm in (A’-C’).
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ciated with kiEphB2 misexpression, suggesting that these
effects arise from an increase in EphB2 forward signal-
ing. In EphB2 transfected embryos, though the average
increase in errors was not significant compared to con-
trols, those with the greater number of targeting errors
were also those with appreciable but not exclusionary
abnormalities in NL morphology.
Eph fusion proteins as inhibitors of Eph signaling
The electroporation studies suggest that EphB2 forward
signaling regulates both axon guidance and auditory
brainstem morphogenesis. We further tested this possi-
bility by inhibiting forward signaling during the time
that NM axons approach their contralateral NL target.
We used unclustered soluble Eph receptor fusion pro-
teins to inhibit forward signaling by endogenous ligands.
The fusion proteins only differ at their C-terminal
region, either having or lacking an Eph receptor extra-
cellular domain, with an identical IgG-Fc region at the
N-terminus. We first demonstrated that EphB1-Fc has
the expected binding properties based on known expres-
sion patterns of ephrin-B ligands in the chick auditory
brainstem (Figure 4). Adjacent sections of cryosectionedtissue were incubated with either EphB1-Fc or IgG-Fc,
followed by labeling with the same secondary fluorescent
anti-Fc antibody. Nuclear counterstaining with bisbenzamide
was used to identify NL (Figure 4A’, B’). While IgG-Fc
treatment showed no immunolabeling (Figure 4A), we
found that EphB1-Fc preferentially binds regions of the
auditory brainstem where ephrin-B ligands are highly
expressed at the age examined, including the midline and
NM-NL neuropil (Figure 4B).
Broad inhibition of Eph signaling impairs axon targeting
and NL morphogenesis
Because soluble fusion proteins are subject to degrad-
ation, the competitive inhibition assays were all per-
formed in an ex ovo preparation that provided access
to the brainstem at later embryonic ages and permitted
injections in a localized region over the course of sev-
eral days. Fusion proteins solubilized in PBS were
injected into the developing hindbrain and fourth ven-
tricle for four consecutive days from E6 to E9, when
contralateral-projecting NM axons have already crossed
the midline and are approaching their NL target [13].
Since it is possible that multiple Eph-ephrin pathways
coordinate axon targeting of this pathway, we performed
Figure 4 Eph receptor fusion protein binds endogenous ephrin
ligands. (A) and (B) are adjacent coronal sections of an E10 embryo,
incubated with either IgG-Fc (A, A’) or EphB1-Fc (B, B’) fusion
proteins. Bisbenzamide nuclear staining of the same section
(A’ and B’ for A and B, respectively) is used to identify NM and NL.
White arrows indicate the ventral border of NL neuropil, and black
arrows indicate the margins of the midline, both are locations where
ephrin-B ligands are highly expressed at this age. EphB1- Fc binds
NL and midline regions (B), whereas IgG-Fc does not (A). Scale
bar = 100 μm.
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used to exclusively inhibit EphB forward signaling be-
cause EphB1 only binds ephrin-B ligands. EphA4-Fc was
used to inhibit all EphA and EphB forward signaling be-
cause, in addition to ephrin-A ligands, EphA4 binds
ephrin-B2, a ligand for both subclasses of Eph receptors.
Our goal here was to discriminate between the effects of
the receptor subclasses, particularly whether EphB sig-
naling was unique or overlapping with EphA signaling.
For negative controls, we had an untreated group and a
group that received injections of human IgG-Fc. A total
of 29 samples were used in the axon targeting analysis
and 35 were used in the analysis of anatomical measure-
ments. Representative images and quantification of tar-
geting errors for each condition are shown in Figure 5.
Embryos with no injections that were prepared ex ovo
had a mean of 9.80 errors ± 1.48 per 400 μm NL (n = 10;
Figure 5A), an error rate that did not differ significantlyfrom control embryos treated with IgG-Fc (Figure 5B;
9.86 ± 1.55 per 400 μm NL, n = 7; P= 0.99). In contrast,
we found there was a significant increase in axon target-
ing errors from NM to contralateral NL after treatment
with EphB1-Fc (Figure 5C; 16.75 ± 3.22 per 400 μm NL,
n = 8, P= 0.04) and with EphA4-Fc (Figure 5D;
26.25 ± 3.09 per 400 μm NL, n = 4, P= 0.0009) as com-
pared to IgG-Fc controls. The effect of EphA4-Fc was
significantly greater than that of EphB1-Fc (P= 0.02; data
summarized in Figure 5E). Often multiple axons were
seen crossing together in EphA4-Fc treated embryos
(Figure 5D) so the number of errors is likely underre-
ported due to our conservative analysis. These data sug-
gest that forward signaling through Eph receptors is
necessary for appropriate axon targeting, and that the
EphA and EphB receptor classes make individual contri-
butions to axon targeting in the NM-NL pathway.
We found that, similar to plasmid electroporated
embryos, NL was often disorganized following EphB1-Fc
or EphA4-Fc injection. However, unlike the embryos
subjected to plasmid electroporation, there were also ap-
preciable targeting abnormalities of NM axons at the
ventrolateral neuropil of NL that were not related to
crossing the NL cell body layer. The percentages of
embryos having any of these atypical morphologies are
shown in Figure 5F. Overall, 82% (9 of 11) of EphB1-Fc
and 75% (6 of 8) of EphA4-Fc injected embryos were
atypical, compared to 17% of combined controls (n = 18).
Of the EphB1-Fc treated embryos, a majority of the
atypical morphologies (7 of 9) were limited to aberrant
projections along the ventrolateral NL neuropil
(Figure 6B) with a normal NL monolayer, whereas NL
formation itself appeared affected more often in EphA4-
Fc treated embryos (4 of 6; Figure 6C).
Impaired development of auditory brainstem nuclei
When embryos were transfected with functional, full-
length EphB2, the development of auditory nuclei was
often impaired, with 75% (12 of 16) of transfected
embryos showing abnormal NL morphology (Figures 3E,
6D). This observation contrasts greatly with controls, as
only 6% (n = 17) and 4% (n = 24) of embryos transfected
with EGFP alone or kiEphB2, respectively, showed ab-
normal morphology. There was wide variation in the
observed range of morphological defects, from merely a
reduced NL extent without disorganization (two cases)
to a severe malformation of both auditory nuclei (two
cases) where NM and NL could not definitively be iden-
tified. In total, six samples were excluded from axon tar-
geting analyses for not meeting the necessary criteria, as
NL was either not identifiable or not presenting as a
monolayer with discrete ventral and dorsal neuropil.
Similar changes in NL were seen with ex ovo inhibition
of EphA and EphB receptors together, where 75% of the
Figure 5 Treatment with Eph receptor fusion protein results in increased targeting errors and atypical NL morphology. (A-D) RDA
tracings of contralateral-projecting NM axons at E10 in untreated embryos (A) or embryos treated during E6 to E9 with IgG-Fc control (B),
EphB1-Fc (C), or EphA4-Fc (D). Axonal processes inappropriately cross the NL cell body layer, terminating in the dorsal NL neuropil in embryos
treated with EphB1-Fc or EphA4-Fc (white arrows, C, D). (E) Quantification of mean axon targeting errors and (F) percentage of embryos with an
atypical NL (including either atypical NL morphology or atypical NL border or both). Scale bar = 25 μm.
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disorganization at the NL layer (Figures 5F and 6E), two
of which were severe enough to exclude them from ana-
lysis of targeting errors. The remaining samples with ac-
ceptable axon tracing often displayed an unusual pattern
of axonal projections that appeared to extend past NL
and terminate in a laterally adjacent brainstem region.
Of embryos receiving EphB1-Fc injections to inhibit
EphB receptors alone, only 18% displayed an abnormal
NL morphology, but aberrant laterally projecting NM
axons were observed in 72% of the cases (n = 11;
Figure 6B) and these axons were more numerous and
appeared to extend farther than in cases with EphA4-Fc
injection.
We found that 17% of the ex ovo control cases (n = 18)
also displayed some aberrant lateral projections but to a
much lesser extent than treated embryos. These aberrant
lateral projections were never observed with any of the
in ovo preparations. Thus, it is possible the impaired lat-
eral targeting is permitted within the ex ovo preparation
and is exacerbated by the inhibition of Eph signaling.
Several anatomical variables were quantified, including
rostrocaudal and mediolateral lengths of NL (Figure 6E,
F) as well as distance and angle between NM and NL
(not significant, data not shown). For embryos overex-
pressing wild-type EphB2, measures were consistently
reduced across variables as compared to controls. The
rostrocaudal and mediolateral extents of NL were both
significantly reduced (p = 0.03 and P= 0.001 respect-
ively). For embryos treated with EphA4-Fc, the rostro-
caudal extent of NL was significantly reduced compared
to IgG-Fc controls (P= 0.0169). An example of a severelyreduced NL extent without NL disorganization is shown
in Figure 6D, and a disorganized NL also having a
reduced NL extent is shown in Figure 6C. Group data
for rostrocaudal and mediolateral extents of NL are pre-
sented in Figure 6E, F. Internal controls were used to
analyze in ovo versus ex ovo experiments separately to
exclude any differences associated with the preparations.
Discussion
In this study, we tested the role of EphB signaling in
the guidance of NM axons to dorsal versus ventral den-
dritic regions of NL and in the morphogenesis of these
auditory nuclei. We found that reduction of EphB2 for-
ward signaling, either by kiEphB2 transfection or by
local inhibition with soluble fusion proteins, resulted in
a significant increase in the number of mistargeted
contralateral NM axons as compared to controls. In
addition, there were significantly more targeting errors
when forward signaling through both EphA and EphB
receptor subclasses were inhibited compared to inhib-
ition of EphB receptors alone. While EphB2 electropor-
ation, performed at E2, did not alter axon targeting, we
found that it resulted in abnormal NL morphology in
which NL was significantly shorter along both rostrocau-
dal and mediolateral brain axes than in controls. Mor-
phological defects were also seen with fusion protein
treatment, performed from E6 to E9. EphB1-Fc injec-
tions resulted in markedly aberrant NM projections at
E10 that exceeded the contralateral NL boundary and
projected laterally. EphA4-Fc injections resulted in mal-
formed NL lamina, and aberrant laterally projecting
axons, though less prominent than in EphB1-Fc treated
Figure 6 Development of NL is affected by impaired Eph receptor signaling. Representative 40X images of lateral NL following RDA midline
tracing of E10 control embryos (A), embryos treated with EphB1-Fc (B), EphA4-Fc (C), or transfected with full-length EphB2 (D). Top panels are a
merge of bisbenzamide (BIS, blue) nuclear counterstaining and RDA (red) fluorescence from labeled contralateral NM axons; both channels are
shown individually in respective middle and lower panels. NL is normally an elongated, flattened layer with a lateral border (leftmost on these
images) well defined by contralateral NM axons (white arrowhead in A). Treatment with EphB1-Fc (B) results in disorganized NM axons projecting
lateral to the NL border (white arrowhead in B). Treatment with EphA4-Fc results in an abnormal NL morphology, where the mediolateral length
is reduced and the lateral aspect is disorganized and not flattened (C). NM is normally found dorsomedial to NL and not within the same
imaging field at 40X magnification, but the positioning of NM relative to NL is altered following transfection with full-length EphB2 at E2 (D) or
treatment with EphA4-Fc from E6 to E9 (C). Measurements of NL (E, F) demonstrate the reduced extent of NL along both rostrocaudal (E) and
mediolateral (F) axes when EphB2 is overexpressed from E2, and along the rostrocaudal axis (E) when all Eph receptors are inhibited with
EphA4-Fc injection from E6 to E9. Scale bar = 100 μm, left is lateral and dorsal is up.
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caudal axis with no change in mediolateral length com-
pared to IgG-Fc injected and untreated controls. Together,
these studies demonstrate several distinct functions for
Eph proteins in the formation and connections of NM
and NL.
Forward EphB2 signaling guides NM axons
We previously showed that misexpression of EphA4
resulted in a significant number of targeting errors in
which contralateral NM axons extended into the dor-
sal NL neuropil [17]. The expression of EphA4 in NL
and not NM, together with the observation that EphA4
and kiEphA4 had similar effects, suggested a non-
cell-autonomous role in which EphA4 in the target sti-
mulates NM attraction through reverse signaling in NM
axons. While those studies were initially motivated bythe asymmetric expression of EphA4 in NL neuropil
regions [44], the finding that many NM axons retained
their appropriate targeting after misexpression prompted
us to consider the potential roles of other Eph proteins.
While EphA4 was unique among these proteins in its
asymmetry, both EphB2 and ephrin-B1 showed high ex-
pression levels in dorsal and ventral NL neuropil, and
EphB2 and ephrin-B2 were seen in NM axons [27].
The electroporation studies carried out here examined
the role of EphB2 in NM axons. We found that kiEphB2,
but not EphB2, increased targeting errors by NM axon
branches into contralateral dorsal NL. Because kiEphB2
decreases forward signaling while EphB2 increases it,
our results suggest that forward signaling through
EphB2 in NM axons is needed for the restriction of NM
axons. The observation that EphB2 overexpression in
NM axons did not have an opposite effect likely reflects
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Together with our EphA4 study, these results suggest
that bidirectional Eph signaling regulates the binaural
segregation of NM axons in NL.
Based on our previous expression analysis [27],
forward signaling through EphB2 in NM axons could be
elicited through (1) ephrin-B1, which might provide
chemorepulsive signals to NM axons entering the ven-
tral NL neuropil, and/or (2) by ephrin-B2, which is
expressed in NL cell bodies and could act as a barrier to
axons to prevent them from reaching the dorsal neuropil
layer. This latter possibility could provide an effective
barrier for both ipsilateral and contralateral NM-NL
projections. As ephrin-B2 is expressed in NM axons
[27], an attractive reverse signaling cue from EphA4 in
the dorsal NL neuropil would then be most effective in
axons dorsal to NL (that is, from ipsilateral NM), which
were not exposed to these chemorepulsive cues.
The expression of EphB receptors and ephrin-B
ligands in both axon and target suggests several possible
roles for EphB signaling. In addition to axon guidance,
Eph-ephrin signaling, and in particular, EphB signaling,
has a well-documented role in synaptogenesis and syn-
aptic plasticity [48-61]. Because NM-NL synapses form
at about E10, just after axons reach the neuropil area,
the guidance of axons to these regions may be linked to
formation of synapses in the correct regions. Moreover,
forward and reverse signaling may influence each other
due to interactions in cis, whereby ephrins can bind to
Eph receptors within the same cell [62,63] or segregate
laterally into distinct signaling domains [64,65]. These
interactions can lead to downstream signaling and can
alter the availability of either class for binding with pro-
teins in trans [62,63,66,67].
EphA and EphB signaling provide distinct axon
guidance cues
In our fusion protein studies, we found that infusion of
EphA4-Fc resulted in significantly more targeting errors
in the NM-NL pathway than infusion of EphB1-Fc, sug-
gesting that inhibition of EphA and EphB signaling is
more effective than inhibition of EphB signaling alone.
These results are consistent with the observation of ex-
tensive targeting errors with EphA4 electroporation [17]
and suggest that in addition to EphB signaling and
EphA4-ephrin-B2 interactions, EphA4 may facilitate
axon guidance through interactions with ephrin-A
ligands. We have previously demonstrated expression of
ephrin-A2 in the auditory nerve and NL neuropil during
the formation of NM-NL projections [45], indicating its
feasibility as a candidate. Coordinated function between
A and B classes has been shown to guide orderly projec-
tion patterns, notably in retinotectal projections [68-72].
Though we postulate here about loss of normal EphB2repulsive cues, it is also likely EphA4 attractive cues are
affected with EphA4-Fc injection and it would be inter-
esting to explore this by analyzing ipsilateral NM-NL
projections.
While our study focused on targeting of NM axons
to distinct dorsal versus ventral NL regions, selective
inhibition of the EphB class of receptors revealed an
additional dimension of axon guidance for contralater-
ally projecting NM axons along the mediolateral axis. In
particular, EphB fusion proteins resulted in pronounced
lateral overgrowth by NM axons. Unlike the electropor-
ation studies where misexpression was generally limited to
NM axons and led to aberrant dorsoventral targeting, in-
jection of fusion proteins into the hindbrain produced a
broader inhibition that likely included EphB receptors in
the NL neuropil. The observation of lateral overgrowth of
NM axons using this approach may thus indicate that
EphB signals arising in or near NL normally provide che-
morepulsive cues that limit lateral growth.
Morphogenesis of auditory nuclei
In addition to axon targeting errors, manipulations of
Eph signaling also resulted in stereotyped morphological
abnormalities. When EphB2 forward signaling was
increased using plasmid electroporation at E2, prior to
cellular migration and NL flattening into a monolayer,
we observed a significant reduction in the size of NL.
This effect may be a result of impaired migration of NL
cells from the auditory anlage and/or from a reduction
in total NL cells either by changes in cell fate specification
or increased cell death. During normal development, NL
undergoes extensive (84%) cell death as the monolayer
forms [3]. Further analysis of changes in nuclei density and
cell movement over time would be required to evaluate
this possibility rigorously. NL was often disorganized, but
in many cases the laminar appearance of NL was normal.
Given that the majority of transfected cells were in NM,
these results suggest a non-cell-autonomous role for
EphB2 that would implicate NM-NL interactions in gener-
ating the appropriate morphology.
Our observations are consistent with previous reports
that EphB/ephrin-B signaling has been shown to guide
normal cellular migration in mammalian neocortex,
hippocampus and cerebellum [73], avian and Xenopus
neural crest [74-76], and zebrafish notochord [77] and
hindbrain [78], whereby a contact repulsion mechanism
is implicated [79,80]. EphB2 forward signaling in par-
ticular is responsible for lamination of hippocampal den-
tate gyrus cells, another brain region with distinct
dorsal-ventral connectivity [81]. Though Eph-ephrin sig-
naling is bidirectional [82], the abnormal morphologies
were not seen with kiEphB2 transfection, where forward
but not reverse signaling was impaired. Similarly disor-
ganized NM-NL nuclei were also observed when EphA4
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cating Eph receptor forward signaling in normal devel-
opment. Together, these data suggest that forward
signaling through EphA and EphB, possibly through
their common ligand ephrin-B2, is necessary for the nor-
mal separation and organization of NM and NL. Indeed,
inhibition of EphB forward signaling alone during E6 to
E9 typically did not result in malformed nuclei, whereas
inhibition of both subclasses together during E6 to E9
was sufficient to produce malformed nuclei at E10. Be-
cause NL lamination occurs when NM axons approach
NL, it remains unclear whether either process is
dependent on the other. Such an interaction is consist-
ent with the observation that EphA4-Fc treated embryos
often resulted in an abnormal NL morphology and also
had a significant increase in targeting errors compared
to EphB1-Fc treated embryos. Since multiple axons were
often found crossing together following EphA4-Fc treat-
ment, the possibility exists that fasciculation cues may
also have been affected. However, because embryos with
severely malformed nuclei did not meet inclusion cri-
teria for axon targeting analysis, it is difficult to provide
more than a qualitative correlation. Our findings suggest
that integrated actions of Eph receptor signaling are ne-
cessary for migration of auditory nuclei precursor cells
during development and that in turn, appropriate migra-
tion may be necessary for axonal target specification.
Morphogenesis relies on Eph signaling at several
developmental stages
When EphB forward signaling was inhibited using fusion
proteins in ex ovo preparations from E6 to E9, though
NL lamination appeared normal, we observed a ten-
dency for NM axons to overshoot the lateral boundary
of their contralateral NL target, suggesting that during
normal development ephrin-B2 expressing axons may be
limited to ventral NL neuropil by EphB2 forward signaling
in NL cells. However, when forward signaling through
both EphA and EphB was inhibited by EphA4-Fc injection,
we observed more significant morphological defects. Simi-
lar to results for EphB2 electroporation, there was a
reduced rostrocaudal extent of NL compared to controls.
In contrast, the mediolateral extent was unchanged, sug-
gesting that this axis is set earlier in development, while
rostrocaudal extension may be more protracted.
The differences in morphological defects between
treatment groups suggest that Eph proteins have distinct
roles during different developmental phases. Effects seen
with electroporation at E2 could result from early mor-
phogenetic events, such as cell proliferation and forma-
tion of the auditory anlage from precursors in distinct
regions [2,46], as well as later events, such as separation
of NM and NL from the anlage and flattening of the NL
cell body layer [15]. In contrast, effects of fusion proteininfusion at E6 to E9 reflect only these later events. While
electroporation targets mainly NM cells, fusion proteins
diffuse broadly within the brainstem and may affect NM
and NL as well as their surrounding regions. Thus the
cell autonomy of these effects is difficult to determine.
The observation that EphB2 receptor overexpression in
NM led to morphologic defects in NL suggests a role for
reverse signaling, but could also indicate changes in the
levels of available ephrins in NM cells due to interactions
with exogenous EphB2. Though the exact mechanisms
involved here are unknown, perturbations to migratory
pathways of neocortex, cerebellum and hippocampus are
seen with loss of EphB2 and ephrin-B signaling and may
be linked to changes in expression, recruitment and/or
signaling of extracellular matrix proteins such as Reelin
[73,81]. Migrating cortical neurons appear to use EphB
versus EphA signaling differentially in determining radial
versus tangential movement, respectively [80]. Likewise,
our results suggest that Eph proteins have a significant
role in the formation of the auditory brainstem circuit at
several developmental time points, along discrete axes and
for distinct developmental events.
Conclusions
Our experimental results together with known develop-
mental events seen during NM-NL development are
summarized in Figure 7. The precursors for NM and NL
coalesce in the auditory anlage by E5 [15,46]. In the pro-
tracted development of this pathway, NM and NL
undergo morphogenetic changes while NM axons simul-
taneously grow toward their bilateral targets. By E10,
precise topographic connections have formed with ipsi-
lateral and contralateral contacts at distinct regions of
respective dorsal and ventral dendrites.
Together with previous expression and misexpression
studies, our results highlight the complex interactions
between Eph molecules in NM-NL development. In our
model, we propose that EphA4 signaling in dorsal but
not ventral NL neuropil is an attractive cue to ipsilateral
NM axons, whereas the repulsive nature of EphB signal-
ing acts at the NL cell body layer disallowing axons on
either side from crossing the NL monolayer. The segre-
gation of ipsilateral and contralateral NM inputs to NL
could thus arise from the distinct expression patterns of
EphA4 and EphB2 along with the opposing effects of
these proteins on axon growth. This view is consistent
with data on dorsoventral targeting (present study and
[17]), midline axon guidance [13], and the data pre-
sented here on lateral growth of NM axons; it also takes
into account the spatiotemporal expression of Eph fam-
ily proteins in the developing pathway [27,44]. Several
other factors must be considered before we can obtain a
complete account of the mechanisms that give rise to
this highly ordered neural pathway. Significantly, the link
Figure 7 Illustration of Eph-ephrin driven events important for normal development of the NM-NL circuit. Left-sided NM and NL are
schematized in a coronal view similar to sections shown in Figures1, 2, 3, 4, 5, 6 with dorsal up and medial to the right. Migratory and axon
targeting events during embryonic days 5 through 10 (E5 to E10) are described. The black line represents ipsilateral NM projections (that is, those
arising from the left side) and the red line represents contralateral NM projections (that is, those arising from the right side, not shown).
Allen-Sharpley and Cramer Neural Development 2012, 7:29 Page 10 of 14
http://www.neuraldevelopment.com/content/7/1/29between morphogenesis of NM and NL and the con-
comitant growth of axons to precise targets is not
understood. Our studies suggest that a small set of Eph
proteins functions in both processes in distinct ways and
that appropriate targeting could be dependent on matur-
ation of the target. Though all Eph signaling inhibition
treatments caused targeting errors, there were more
errors when all signaling was blocked and unique mor-
phologic outcomes associated with each condition. The
increase in targeting errors when all Eph signaling was
blocked versus EphB signaling alone might reflect an
amplified effect of the same targeting mechanism, a re-
sult of the abnormal morphology per se, or both. While
it is not yet possible to determine how these proteins act
at each stage, or which other molecules contribute to
the assembly of this circuit, our results, together with
previous studies, suggest that coordinated Eph signaling
at multiple steps is needed for the formation, connectiv-
ity and boundary specification of the NM-NL circuit.
Methods
Embryos
Fertilized brown Leghorn chicken eggs (Gallus domesti-
cus) were obtained from AA Laboratories (Westminster,
CA, USA) and stored at room temperature for up to twodays prior to use. To initiate embryonic development,
the eggs were placed in a rotating incubator at 39°C with
a relative humidity above 70%. Chick embryos were ei-
ther electroporated in ovo at E2 or transferred at E3 to a
culture dish for ex ovo experimentation at E6 to E9.
Ex ovo culture dishes were maintained in a non-rotating
incubation chamber of similar temperature and humid-
ity, allowing access to the developing embryo at later
ages than the in ovo preparation. Each ex ovo culture
preparation consisted of a disinfected polystyrene weigh
dish (3.5 X 3.5 X 1 in.) into which the egg was opened,
and a sterile square disposable petri dish bottom (100 X
100 X 15 mm) used as a lid. All embryos were sacrificed
at E10 and the brainstem carefully dissected for in vitro
whole mount axon tracing.
In ovo electroporation
Eggs were removed from the rotating incubator at E2
and a small circular window was cut into the side of the
eggshell following reinforcement with tape and removal
of 3 mL thin albumin. Using a modified 25-guage hypo-
dermic needle, a small amount of 4% India ink (in phos-
phate buffered saline (PBS)) was injected directly
beneath the embryo to permit visualization. The vitelline
membrane was removed with a fine tungsten needle and
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at the level of rhombomere 5 to provide access to the
neural tube. Sterile PBS was placed over the area of
interest to enhance electrical current and protect the
embryo and underlying membranes from electrical
burns. Paired needle-style gold-plated electrodes (Gene-
trodes, Harvard Apparatus, Holliston, MA USA) were
positioned straddling the area of interest, approximately
2 to 3 mm apart. Plasmid DNA (1 to 3 μg/μL in Tris/
EDTA), colored with a small amount of Fast Green dye,
was injected into the neural tube opening using a 1.2
mm pulled glass pipette attached to a Picospritzer
(Parker Hannifin Corporation, Irvine, CA USA). No
more than 100 to 200 nL of plasmid DNA was delivered
using a series of (typically 2 to 6) injections of 20 to
50 ms duration and 20 psi. Voltage was delivered using
a BTX electroporator, with amplitude of 9 to 12 Volts
and 50-ms duration, in trains of four to six pulses of
100 ms intervals. A total of 20 to 30 pulse trains were
delivered for each embryo, with polarity switched
between pulse trains in order to achieve bilateral trans-
fection. All openings in the eggshell were sealed with
tape, and the eggs were placed in a humid, non-rotating
39°C incubation chamber for an additional eight days.
Plasmids
Plasmid vectors were used to introduce DNA via in ovo
electroporation. Full-length EphB2 was cloned into
pCAX at the EcoR1 site and co-transfected with pCAX-
EGFP. The pCAX construct encodes chicken β-actin
promoter, a CMV-IE enhancer, polycloning sites and
poly-A signal. Full-length EphB2 or kinase inactive
EphB2 (kiEphB2; provided by E. Pasquale, Sanford-
Burnham Institute, La Jolla, CA, USA) containing a
point mutation in the intracellular kinase domain was
cloned into the pMES vector at the EcoR1 site. The
pMES construct contains a chicken β-actin promoter, a
CMV-IE enhancer and also encodes an EGFP reporter
with an internal ribosomal entry site. As a negative con-
trol, embryos were transfected with pCAX-EGFP alone.
Transfection was assessed by examination of EGFP
fluorescence in dissected brainstems and in sectioned
material using an epifluorescent microscope. In addition,
we performed immunostaining on transfected embryos
using methods described previously for EphA4 and
EphB2 detection following electroporation [13,17,44].
Recombinant fusion protein injections
A soluble recombinant protein containing the EphB1 re-
ceptor extracellular domain fused to the Fc region of
Human IgG (rat EphB1-Fc; R&D Systems, Minneanapo-
lis, MN, USA) was used to inhibit forward signaling
through EphB receptors. Additionally, mouse EphA4-Fc
(R&D systems) was used to inhibit forward signalingthrough EphA and EphB receptors. Recombinant pro-
teins were diluted to 10 μg/mL in sterile 1X PBS and a
small amount of methylene blue powder (Sigma-Aldrich,
St. Louis, MO, USA) was dissolved into the solution at
37°C immediately prior to use to aid with injection visi-
bility. Final solution was injected into the developing
hindbrain at the floor of the fourth ventricle with a
1.2 mm pulled glass pipette attached to a Picospritzer
using pulses of 20 to 200 ms duration and intensity of
20 psi. Injections were made for four consecutive days,
E6 to E9, when NM axons have already crossed the mid-
line and are approaching their contralateral NL target.
The total volume injected varied from approximately 1.5
to 5.5 μL per embryo for respective E6 to E9 ages.
Human IgG1-Fc (R&D Systems) was used as a negative
control. Fusion protein binding specificity was confirmed
by incubation of fixed 30 μm cryosections with EphB1-
Fc or IgG-Fc overnight, followed by secondary (anti-Fc)
fluorescent antibody incubation for two hours.
Ex vivo axon tracing
Axon tracing was used to identify and quantify targeting
errors. E10 chick embryos were removed from the egg
or the ex ovo culture dish and the brainstem quickly dis-
sected in oxygenated artificial cerebrospinal fluid (aCSF;
130 mM NaCl, 3 mM KCl, 1.2 mM KH2PO4, 20 mM
NaHCO3, 3 mM HEPES, 10 mM Glucose, 2 mM CaCl2,
1.3 mM MgSO4). A pulled glass micropipette with an
approximately 10 μm opening at the tip, was filled with
rhodamine dextran amine (RDA, MW=3,000, Molecular
Probes, Inc., Eugene, OR, USA) made at 6.25% with a
0.4% Triton X-100 in PBS, and attached by fine tubing
to a Picospritzer. Using several pulses ranging from 10
to 50 ms at 20 psi, RDA was pressure injected into the
dorsal midline of the medulla at the floor of the fourth
ventricle to label only contralateral-projecting NM
axons, as described previously [17]. The tissue was
immersed in aCSF continuously infused with 95% O2/5%
CO2 for 15 minutes. The tissue was then prepared for
histologic sectioning as described in the next section
and the axon tracings were later visualized by fluores-
cent microscopy.
Histology
Tissue was fixed in 4% paraformaldehyde (PFA) in PBS
for at least 2 hours, and then washed in 1X PBS for 10
minutes. For Vibratome sectioning, tissue was embedded
in 2% low-melting agar (Fisher Scientific, Pittsburgh, PA,
USA) and mounted to the stage, fully immersed in 1X
PBS during sectioning. For cryostat sectioning, tissue
was cryoprotected in 30% sucrose overnight prior to em-
bedding in OCT medium. For all tissues, sequential 50
μm sections in the coronal plane were collected on a
subbed glass slide and dried on a slide warmer at 37°C.
Allen-Sharpley and Cramer Neural Development 2012, 7:29 Page 12 of 14
http://www.neuraldevelopment.com/content/7/1/29Most sections were counterstained with the nuclear stain
bisbenzimide (2 μg/mL in PBS, five minutes incubation
followed by five minutes 1X PBS wash) to facilitate identi-
fication of NM and NL. Slides were coverslipped with
Glycergel mounting medium (Dako, Carpinteria, CA,
USA) and stored in the dark at 4°C until analyzed. A sep-
arate group of samples underwent immunofluorescence
staining to confirm plasmid expression or fusion protein
location. These samples were sectioned on the cryostat as
described above into 25 μm sections.
Immunofluorescence
Immunostaining was performed on a subset of samples
to confirm plasmid expression with anti-EphB2 primary
antibody or to confirm fusion protein localization with
anti-Fc secondary antibody. Briefly, a hydrophobic pap-
pen border was drawn around the sections and the slides
were rinsed then incubated in blocking solution (4% goat
serum, 0.01% Triton in 1X PBS) for one hour at room
temperature in a humid chamber. The slides were
quickly rinsed with PBS and then incubated with the pri-
mary antibody for confirmation of plasmid expression,
or with secondary antibody for visualization of fusion
protein localization. For slides undergoing primary anti-
body labeling, slides were rinsed after one day then
incubated with the secondary antibody for labeling.
All secondary antibody labeling was performed with
Alexa Fluor anti-Fc antibodies (Molecular Probes, Inc.,
Eugene, OR, USA) used at a 1:1,000 dilution in blocking
solution and incubated for two hours at room
temperature in the dark.
Image and data analysis
Experimental embryos with no gross abnormalities were
used at E10 for data collection. Criteria for inclusion in
further analysis were EGFP expression in the auditory
brainstem of transfected embryos, four days of success-
ful hindbrain injections for ex ovo cultured embryos, and
successful midline axon tracing. Samples were coded
and analyzed blind to experimental conditions. The
slides were viewed on a Zeiss AxioSkop-2 epifluores-
cence microscope (Carl Zeiss, Thornwood, NY, USA)
using 10X, 20X or 40X objective lenses. To quantify
NM-NL axon targeting errors, NL was viewed at 20 and
40X across several focal planes in order to allow for sys-
tematic analysis of the entire width of every section. Tar-
geting errors were defined as axons arising from
contralateral NM that crossed the NL cell body layer to
terminate in the dorsal neuropil, visible as a cell-free
layer with bisbenzimide staining and dorsal to NL
somata. At this age in development, NL was typically
visible across at least eight sections, or 400 μm of coron-
ally sectioned brain. Since the central region of this ex-
tent is where NL presents robustly as a single layer ofcells (assuming no anatomical variation exists), this is
the area where targeting errors can be most accurately
quantified. Thus, for each embryo, n = 1 and a total of
400 μm of NL extent was analyzed, typically 200 μm
(four adjacent sections X 50 μm each) from each left
and right sides of the brain, at the central region along
the NL axes. Mediolateral lengths were measured with
Openlab software (Perkin Elmer, Waltham, MA, USA)
by recording the distance between the medial-most and
lateral-most borders of identifiable NL soma in equiva-
lent sections. Rostrocaudal lengths were measured by
counting the number of adjacent sections containing NL
soma and multiplying by 50 (the thickness of each sec-
tion). Left and right sides were recorded separately for
anatomical measures. Once data collection was
complete, the samples were decoded and grouped for
comparison of means. Representative images were taken
with Zeiss Axiocam digital camera and Openlab soft-
ware. Any additional image analysis, tiling and color ren-
dering or color merging was performed with Adobe
Photoshop (Adobe, San Jose, CA, USA) and figures were
prepared with Adobe Illustrator. All statistical analyses
were done with JMP software (JMP, Cary, NC, USA)
using a Student’s t-test and a significance value of
P < 0.05.
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